Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd. (SHE:300357)

Market Cap	14.04B +37.3%
Revenue (ttm)	1.05B +15.9%
Net Income	390.43M +25.0%
EPS	0.75 +25.0%
Shares Out	523.58M
PE Ratio	35.97
Forward PE	34.83
Dividend	0.22 (0.82%)
Ex-Dividend Date	Jan 20, 2026

Volume	5,583,044
Average Volume	5,068,184
Open	27.70
Previous Close	26.99
Day's Range	26.60 - 27.70
52-Week Range	18.60 - 35.84
Beta	0.67
RSI	25.84
Earnings Date	Apr 24, 2026

About SHE:300357

Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd., a biopharmaceutical company, engages in the research, development, production, and sale of pharmaceutical products for the diagnosis and treatment of allergic diseases in China and internationally. The company offers Changdi, a dust mine drops; Changhao, an artemisia annua pollen allergen sublingual drops; and Changdian, a dust mite skin prick diagnostic kit. It also involved in the research and development of stem cells and medical artificial intelligence solutions. The company was founded in 2002 a...

• Industry: Drug Manufacturers - General
• Sector: Healthcare
• Founded: 2002
• Employees: 1,679
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 300357

Financial Performance

In 2024, SHE:300357's revenue was 925.39 million, an increase of 9.10% compared to the previous year's 848.19 million. Earnings were 317.82 million, an increase of 2.46%.